Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016 - GlobalData

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016 - GlobalData
Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016
Published Oct 01, 2016
142 pages — Published Oct 01, 2016
Price US$ 4,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016' provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Abdominal Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0225EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents28
  1.1 List of Tables63
  1.2 List of Figures91
2 Introduction101
  2.1 Abdominal Aortic Stent Grafts Overview101
3 Products under Development115
  3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development111
  3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory121
  3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path131
  3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date141
  3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials151
4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies163
  4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development161
  4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development172
5 Abdominal Aortic Stent Grafts Companies and Product Overview1962
  5.1 BiFlow Medical Ltd Company Overview191
    5.1.1 BiFlow Medical Ltd Pipeline Products &Ongoing Clinical Trials Overview192
  5.2 Bolton Medical, Inc. Company Overview211
    5.2.1 Bolton Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview215
  5.3 Cardiatis SA Company Overview261
    5.3.1 Cardiatis SA Pipeline Products &Ongoing Clinical Trials Overview261
  5.4 Cardiovate Company Overview271
    5.4.1 Cardiovate Pipeline Products &Ongoing Clinical Trials Overview271
  5.5 Cook Medical Incorporated Company Overview281
    5.5.1 Cook Medical Incorporated Pipeline Products &Ongoing Clinical Trials Overview285
  5.6 Cordis Corporation Company Overview331
    5.6.1 Cordis Corporation Pipeline Products &Ongoing Clinical Trials Overview334
  5.7 Cytograft Tissue Engineering, Inc. Company Overview371
    5.7.1 Cytograft Tissue Engineering, Inc. Pipeline Products &Ongoing Clinical Trials Overview371
  5.8 Endologix, Inc. Company Overview381
    5.8.1 Endologix, Inc. Pipeline Products &Ongoing Clinical Trials Overview3813
  5.9 Endoluminal Sciences Pty Ltd. Company Overview511
    5.9.1 Endoluminal Sciences Pty Ltd. Pipeline Products &Ongoing Clinical Trials Overview511
  5.10 EndoSpan Ltd Company Overview521
    5.10.1 EndoSpan Ltd Pipeline Products &Ongoing Clinical Trials Overview525
  5.11 Lombard Medical Technologies Inc. Company Overview571
    5.11.1 Lombard Medical Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview575
  5.12 Lombard Medical Technologies Limited Company Overview621
    5.12.1 Lombard Medical Technologies Limited Pipeline Products &Ongoing Clinical Trials Overview621
  5.13 Medtronic plc Company Overview631
    5.13.1 Medtronic plc Pipeline Products &Ongoing Clinical Trials Overview632
  5.14 MicroPort Scientific Corporation Company Overview651
    5.14.1 MicroPort Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview652
  5.15 St. Jude Medical, Inc. Company Overview671
    5.15.1 St. Jude Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview672
  5.16 TriVascular, Inc. Company Overview691
    5.16.1 TriVascular, Inc. Pipeline Products &Ongoing Clinical Trials Overview696
  5.17 University of Limerick Company Overview751
    5.17.1 University of Limerick Pipeline Products &Ongoing Clinical Trials Overview751
  5.18 Venus MedTech Company Overview761
    5.18.1 Venus MedTech Pipeline Products &Ongoing Clinical Trials Overview761
  5.19 W. L. Gore &Associates, Inc. Company Overview771
    5.19.1 W. L. Gore &Associates, Inc. Pipeline Products &Ongoing Clinical Trials Overview774
6 Abdominal Aortic Stent Grafts- Recent Developments8158
  6.1 Sep 20, 2016: Endologix Reports Positive Clinical Data from Ovation LIFE (Least Invasive Fast-Track EVAR) Study811
  6.2 Sep 18, 2016: MicroPort Endovascular Minos Ultra Low Profile AAA Stent-Graft Completes Patient Enrollment of Pre-market Clinical Trials821
  6.3 Sep 16, 2016: Cardiovate Raises USD0.15 Million in Venture Financing821
  6.4 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services821
  6.5 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China831
  6.6 Aug 30, 2016: MPSC Announces 2016 Interim Results832
  6.7 Aug 25, 2016: Medtronic Reports First Quarter Financial Results852
  6.8 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2871
  6.9 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2881
  6.10 Aug 22, 2016: Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives891
  6.11 Aug 17, 2016: Endologix Announces First Patients Treated with Ovation Alto Abdominal Stent Graft System901
  6.12 Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016911
  6.13 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%)921
  6.14 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results932
  6.15 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic951
  6.16 Jun 16, 2016: Lombard Medical to Initiate the Altura ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of Real-World Endovascular Aneurysm Repair Interventions951
  6.17 Jun 13, 2016: Lombard Medical Reports Positive Five-Year Aorfix Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy961
  6.18 Jun 09, 2016: Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy971
  6.19 Jun 08, 2016: Lombard Medical Provides Update on Controlled Launch of the New Altura Endovascular Stent Graft in Europe981
  6.20 Jun 07, 2016: Final Subject Enrolled in Early Feasibility Study of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis991
  6.21 Jun 06, 2016: Lombard Medical Receives Australian Therapeutic Goods Administration (TGA) Approval for the Aorfix Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms1001
  6.22 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day1001
  6.23 Jun 02, 2016: GORE EXCLUDER Conformable AAA Endoprosthesis Obtains CE Mark1011
  6.24 Jun 02, 2016: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft Five-Year Clinical Data at the 2016 Society for Vascular Surgery Annual Meeting1011
  6.25 May 31, 2016: Lombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on Improving Endovascular Aneurysm Repair (EVAR) Treatment using the Aorfix Endovascular Stent Graft at the 2016 Japanese Society for Vascular Surgery An...1021
  6.26 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results1032
  6.27 May 26, 2016: Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study1051
  6.28 May 19, 2016: Lombard Medical Announces Scientific Presentation on Altura Endograft System at the International Symposium on Endovascular Therapeutics, SITE Update 20161061
  6.29 May 19, 2016: Lombard Medical Announces Presentation on Aorfix Endovascular Stent Graft at the International Symposium on Endovascular Therapeutics1071
  6.30 May 17, 2016: Lombard Medical Releases Positive Early Results from the Altura Endograft System Clinical Evaluation1081
  6.31 May 16, 2016: Endologix Completes Patient Enrollment in the Ovation LIFE (Least Invasive Fast-Track EVAR) Study1081
  6.32 May 13, 2016: MicroPort Attends CICE 20161091
  6.33 May 11, 2016: Lombard Medical Reports 2016 First Quarter Financial Results1091
  6.34 May 09, 2016: Endologix Reports Results for the First Quarter 20161102
  6.35 Apr 28, 2016: Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium1121
  6.36 Apr 27, 2016: Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium1121
  6.37 Apr 27, 2016: Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial1131
  6.38 Apr 21, 2016: Lombard Medical Announces Scientific Presentation on Altura Endovascular Stent Graft at the 38th Annual Charing Cross International Symposium1141
  6.39 Apr 21, 2016: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft at the 38th Annual Charing Cross International Symposium1151
  6.40 Apr 21, 2016: Lombard Medical Announces Scientific Presentations on Altura and Aorfix Endovascular Stent Grafts at the 38th Annual Charing Cross International Symposium1161
  6.41 Apr 14, 2016: Lombard Medical Completes First Altura Endovascular Stent Graft Live Case Training Workshop for German Physicians1171
  6.42 Apr 11, 2016: Endologix Announces CE Mark for Next-Generation Nellix EndoVascular Aneurysm Sealing System1181
  6.43 Apr 04, 2016: Lombard Medical Provides Update on New Altura Endovascular Stent Graft Launch1191
  6.44 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device1191
  6.45 Mar 09, 2016: Lombard Medical Completes First Altura Endovascular Stent Graft Live Case Physician Training Workshop1191
  6.46 Mar 08, 2016: Endologix Announces First Patients in Japan Treated With Nellix EndoVascular Aneurysm Sealing System1201
  6.47 Mar 03, 2016: Lombard Medical s New Altura Endovascular Stent Graft to be Presented at 9th Annual Houston Aortic Symposium1201
  6.48 Feb 29, 2016: Endologix Announces First U.S. Commercial Implant of AFX2 Bifurcated Endograft System1211
  6.49 Feb 24, 2016: Lombard Medical Announces First Commercial Altura Endovascular Stent Graft Procedure in Germany Following LINC1211
  6.50 Feb 22, 2016: Endologix Reports Results for the Fourth Quarter and Full Year 20151221
  6.51 Feb 16, 2016: GORE EXCLUDER Device Reaches Significant Milestone1231
  6.52 Feb 04, 2016: Lombard Medical Announces First Commercial Altura Endovascular Stent Graft Procedure1241
  6.53 Jan 27, 2016: Lombard Medical Announces Completion of Altura Endovascular Stent Graft Live Case Presentation at the 12th Annual Leipzig Interventional Course1241
  6.54 Jan 21, 2016: Lombard Medical Announces First Ever Altura Endovascular Stent Graft Live Clinical Case Presentation at the 12th Annual Leipzig Interventional Course1251
  6.55 Jan 21, 2016: Lombard Medical presents Aorfix Endovascular Stent Graft at the 12th Annual Leipzig Interventional Course1251
  6.56 Jan 12, 2016: First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study1261
  6.57 Dec 10, 2015: Endologix AFX Endovascular AAA System Receives Shonin Approval for Marketing in Japan1271
  6.58 Dec 10, 2015: First Patient Treated in Canada After 2015 In-Country Approval of Cook Medical s Zenith Alpha Abdominal Endovascular Graft1271
  6.59 Nov 30, 2015: Three-Year Follow-Up Data From Lombard Medical Aorfix PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium1281
  6.60 Nov 19, 2015: Strong Results Reported for the Cordis INCRAFT AAA Stent Graft System with New Four-Year Data from the INNOVATION Trial1291
  6.61 Nov 19, 2015: Positive Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at 2015 VEITH Symposium1301
  6.62 Nov 18, 2015: Leading Physicians to Initiate ASCEND Registry for Nellix EVAS System1301
  6.63 Nov 18, 2015: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft at the 42nd Annual VEITHsymposium1311
  6.64 Nov 18, 2015: Lombard Medical Announces Scientific Presentation on Altura Endovascular Stent Graft at the 42nd Annual VEITHsymposium1321
  6.65 Nov 17, 2015: Medtronic's Endurant AAA Stent Graft Delivers Durable, Consistent and Proven Outcomes at Four Years in Real-World Setting1331
  6.66 Nov 03, 2015: Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 20151341
  6.67 Oct 26, 2015: Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 20201341
  6.68 Oct 26, 2015: Endologix Acquires TriVascular Technologies1351
  6.69 Oct 26, 2015: Endologix Reports Third Quarter 2015 Financial Results1361
  6.70 Oct 16, 2015: Bolton Medical Announces the First Patient Treated with the New TREO Abdominal Stent-Graft System1371
  6.71 Oct 15, 2015: EndoSpan Raises USD10 Million in Private Placement of Shares1371
  6.72 Oct 12, 2015: Endologix Announces FDA Approval of AFX 2 Bifurcated Endograft System1372
7 Appendix1394
  7.1 Methodology1392
  7.2 About GlobalData1411
  7.3 Contact Us1411
  7.4 Disclaimer1421

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016" Oct 01, 2016. Alacra Store. May 13, 2025. <http://www.alacrastore.com/storecontent/GlobalData/Abdominal-Aortic-Stent-Grafts-Medical-Devices-Pipeline-Assessment-2016-2085-23753>
  
APA:
GlobalData. (2016). Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016 Oct 01, 2016. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/storecontent/GlobalData/Abdominal-Aortic-Stent-Grafts-Medical-Devices-Pipeline-Assessment-2016-2085-23753>
  
US$ 4,000.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.